Age and gender may affect posterior reversible encephalopathy syndrome in renal disease

被引:34
作者
Yamada, Akio [2 ]
Ueda, Norishi [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Dev Pediat, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Social Insurance Chukyo Hosp, Dept Pediat, Nagoya, Aichi, Japan
关键词
Age; Calcineurin inhibitors; Gender; Hypertension; Nephrotic syndrome; Posterior reversible encephalopathy syndrome; Renal insufficiency; LEUKOENCEPHALOPATHY; NEUROTOXICITY; PATIENT;
D O I
10.1007/s00467-011-1974-y
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
It remains elusive what factors affect posterior reversible encephalopathy syndrome (PRES). Eleven PRES children, all with acute glomerulonephritis, Alport syndrome, and lupus nephritis, 5 with nephrosis, and 3 renal transplant recipients, were studied. PRES recurred in 1 patient. Neurological symptoms were graded as 1: mild (headache, nausea/vomiting, or tremor), 2: moderate (vision change), and 3: severe (mental dysfunction, cerebellar symptoms, seizures, recurrence of seizures, and coma). Magnetic resonance imaging was graded as 1: subtle change, 2: abnormal large areas, and 3: complete involvement of the regions. The common symptoms were seizures (100%), headache (82%), nausea/vomiting (73%), coma (55%), and vision change (46%). Seizures recurred in 7 (64%). All but one (91%) developed hypertension and 7 (64%) received calcineurin inhibitors (CNI). Edema occurred in 7 (64%) and renal insufficiency/end-stage renal disease (ESRD) in 4 (36%). Seizures recurred frequently in younger patients. Symptoms were severe in girls. Duration or severity of the condition with predisposing factors (hypertension, CNI, nephrosis or renal insufficiency/ERSD) did not make a difference in the symptoms and neuroimaging. Two patients developed chronic epilepsy. Age and gender may affect PRES symptoms. Our results are limited by small sample size and should be determined using larger numbers of patients.
引用
收藏
页码:277 / 283
页数:7
相关论文
共 31 条
[1]   Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients [J].
Akutsu, N. ;
Iwashita, C. ;
Maruyama, M. ;
Ootsuki, K. ;
Ito, T. ;
Saigo, K. ;
Kenmochi, T. .
TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) :2416-2418
[2]   Seizures following renal transplantation in childhood [J].
Awan, AQ ;
Lewis, MA ;
Postlethwaite, RJ ;
Webb, NJA .
PEDIATRIC NEPHROLOGY, 1999, 13 (04) :275-277
[3]   Understanding the Genetic Basis for Adverse Drug Effects: The Calcineurin Inhibitors [J].
Bai, Jane P. F. ;
Lesko, Lawrence J. ;
Burckart, Gilbert J. .
PHARMACOTHERAPY, 2010, 30 (02) :195-209
[4]   Posterior reversible encephalopathy syndrome, part 1: Fundamental imaging and clinical features [J].
Bartynski, W. S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) :1036-1042
[5]   Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema [J].
Bartynski, W. S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) :1043-1049
[6]  
Bartynski WS, 2006, AM J NEURORADIOL, V27, P2179
[7]  
Bechstein WO, 2000, TRANSPL INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x
[8]  
Besenski N, 2005, AM J NEURORADIOL, V26, P2282
[9]   Posterior reversible encephalopathy syndrome in childhood cancer [J].
de Laat, P. ;
te Winkel, M. L. ;
Devos, A. S. ;
Catsman-Berrevoets, C. E. ;
Pieters, R. ;
van den Heuvel-Eibrink, M. M. .
ANNALS OF ONCOLOGY, 2011, 22 (02) :472-478
[10]   Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome Frequency, Features, and Risk Factors [J].
Ducros, Anne ;
Fiedler, Ursula ;
Porcher, Raphael ;
Boukobza, Monique ;
Stapf, Christian ;
Bousser, Marie-Germaine .
STROKE, 2010, 41 (11) :2505-2511